Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Response from CEO, CHAI about the Quick Start program in November 2016
Response from CEO, CHAI about the Quick Start program in November 2016
Please click here
December 21, 2016
/
News
Share
the Post
Related
Posts
The use of generic DAAs for hepatitis C treatment, Freeman et al 2016
Patent Situation of The Key Product for Treatment of Hepatitis C: DACLASTAVIR – WHO working paper, revised version, Oct 2014
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
Know the interactions between HIV and Hep C medicines
Updated WHO screening, care and treatment of persons with hepatitis C infection_ April 2016.
Read More
Story from Ayu Oktariani, Bandung, Indonesia
Patient Groups and CSOs in Asia written a letter to Indian Government to Request Waiver on Local Clinical Trial for The Coming Generic DAAs
Flawed patents on hepatitis C drugs latest to be challenged in global push for access
